Navigation Links
Research and Markets - Global Multiple Myeloma Drugs Market 2017-2021 with Amgen, Celgene, Johnson & Johnson, Novartis & Takeda Pharmaceuticals Dominating
Date:1/16/2017

DUBLIN, Jan 16, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Multiple Myeloma Drugs Market 2017-2021" report to their offering.

Global multiple myeloma drugs market to grow at a CAGR of 9.19% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global multiple myeloma drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent multiple myeloma. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers for this market is growing demand for biologic therapies. The market has been witnessing a growing demand for biologic therapies, which is expected to drive market growth. Biologic therapy is a treatment that triggers the body's immune system to fight myeloma cells. Biologic therapies boost the immune system cells that identify and attack cancer cells. The demand for targeted therapies is due to its higher efficacy than other conventional therapies, which involves in destroying healthy cells too.

The latest trend gaining momentum in the market is emergence of nanomedicine platform. The market has witnessed the emergence of nanomedicine, which is likely to have a positive impact. The lipid-based nanoparticles and polymer-based approaches for the drug delivery are gaining traction in the market, owing to the limitations of current technologies. The existing technologies need numerous cells to detect the presence of a tumor.

Further, the report states that the growing popularity of CAM is expected to hinder growth prospects in the market. With the increasing side effects of conventional drugs, the individuals are seeking CAM therapies. The increased demand for these therapies is also due to the high cost of multiple myeloma therapeutics.

Key vendors

  • Amgen
  • Celgene
  • Johnson & Johnson
  • Novartis
  • Takeda Pharmaceuticals

Other prominent vendors

  • AB Science
  • AbbVie
  • Bristol-Meyer Squibb
  • Celldex Therapeutics
  • Eureka Therapeutics
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • ImmunoGen
  • Immunomedics
  • Innate Pharma
  • JW Pharmaceutical
  • Merck
  • Oncolytics Biotech
  • Ono Pharmaceutical
  • Otsuka Pharmaceuticals
  • Prothena Therapeutics
  • Sanofi

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Disease overview

Part 06: Pipeline analysis

Part 07: Market landscape

Part 08: Market segmentation by therapy

Part 09: Geographical segmentation

Part 10: Market drivers

Part 11: Impact of drivers

Part 12: Market challenges

Part 13: Impact of drivers and challenges

Part 14: Market trends

Part 15: Vendor landscape

Part 16: Key vendor analysis

Part 17: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/zkdjx6/global_multiple

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-multiple-myeloma-drugs-market-2017-2021-with-amgen-celgene-johnson--johnson-novartis--takeda-pharmaceuticals-dominating-300391332.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Non-Invasive Prenatal Testing (NIPT) Market 2011-2021: Natera Panorama Test will Lead the NIPT Test Market 25% of the Market Share - Research and Markets
2. Vital Signs Monitoring Devices Market is Expected to Reach $5,491 Million by 2022, Globally - Allied Market Research
3. Sterilization Technologies Market Expected to Reach $8,578 Million by 2022, Globally - Allied Market Research
4. Antioxidants Market Expected to Reach $4,531 Million by 2022, Globally - Allied Market Research
5. Dovetail Genomics Launches New Genome Assembly Service Designed to Provide Researchers with Chromosome-Scale Genome Assemblies
6. Research Reports Coverage on Medical Equipment Stocks -- Wright Medical, Varian Medical Systems, MiMedx, and NuVasive
7. How These Research Services Stocks are Faring? -- Myriad Genetics, Qiagen, INC Research, and La Quinta
8. Global Cystic Fibrosis Heat Map and Analysis 2016-2022 - Research and Markets
9. Global Melanoma Heat Map and Framework Analysis Report 2016-2022: Pipeline Products & Marketed Products - Research and Markets
10. Global Immunotherapy Drugs Market to Reach $201 Billion by 2021: Increasing Adoption of Targeted Therapies - Research and Markets
11. In Vitro Diagnostics (IVD) Quality Control Products Market is Expected to Reach $1,052 Million by 2022, Globally - Allied Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2019)... , ... October 11, 2019 , ... Based on data ... a 9 percent increase in deceased organ donors over 2018. Through August 31, 7,786 ... Transplantation Network (OPTN) national database . At this pace, the Association of Organ ...
(Date:10/10/2019)... ... October 10, 2019 , ... ... Cocktail Reception on Thursday, September 26, at the Westchester Country Club in Rye. ... unwavering support of the organization and its mission. , “In Celebration” featured live ...
(Date:10/8/2019)... Pa. (PRWEB) , ... October 09, 2019 , ... “When ... the emotions, frustrations, and the realities of the HEMS world through telling the real ... Helicopter Pilot” is the creation of published author Jay A. Humphrey, an EMS helicopter ...
Breaking Medicine Technology:
(Date:10/17/2019)... SANTA BARBARA, Calif. (PRWEB) , ... October 17, 2019 , ... ... one ingenious magnetic roller case, quickly broke its campaign goal– raising more than $20,000 ... see the response from the crowdfunding community, who’ll be the first to enjoy the ...
(Date:10/17/2019)... ... , ... Whole Foods Market, along with Austin leaders, has joined forces with ... an in-depth assessment by the Blue Zones team of the Austin Metro area and ... to live, work, grow up, and grow old. , Blue Zones is based on ...
(Date:10/15/2019)... (PRWEB) , ... October 15, 2019 , ... ... with FDA’s Most Recent IFU Guidance , **An FDAnews Webinar**, Tuesday, October 29, ... Instructions for Use (IFU) guidance have on new drug applications and biologics license ...
(Date:10/15/2019)... ... , ... Nashville Fertility Center (NFC) is proud to announce that Kristin ... In addition to treating general infertility, Dr. Van Heertum offers expertise in fertility surgery ... to Dr. Van Heertum joining the practice and believes she is the perfect fit. ...
(Date:10/11/2019)... DALLAS (PRWEB) , ... October 11, 2019 , ... A ... Alliance (STA) new headquarters facility by general contractors Adolfson & Peterson Construction. The event ... of 2020 at 8190 Midtown Road in Dallas. The first of its kind in ...
Breaking Medicine News(10 mins):